Weight management and cardiovascular risk reduction: The role of Semaglutide 2.4mg
Description
In this Product Explainer, Dr. Robert Hungerford, GP with a special interest in ASCVD, heart failure and diabetes, explains the role of Semaglutide 2.4mg in weight management and cardiovascular risk reduction in secondary prevention (7 mins).
NEXT LIVE Webcast
:
Days
:
Hours
:
Minutes
Seconds
Dr Emily Nash
Abnormal Liver Function Test
Prof Richard Harvey
Recurrent Nasal Polyps Management – When to Refer
Prof Kelly-Anne Phillips
Breast Density and Cancer Risk – What Every GP Can Put into Practice Tomorrow
A/Prof Adrian Mar
Vitiligo – Early Detection and Early Treatment
Join us for the next free webcast for GPs and healthcare professionals
High quality lectures delivered by leading independent experts
